Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 10:12 PM
Ignite Modification Date:
2025-12-25 @ 7:48 PM
NCT ID:
NCT02752035
Group ID:
EG003
Title:
Randomized Cohort: Gilteritinib
Description:
Participants received 120 mg (3 tablets of 40 mg) of gilteritinib orally once daily for continuous 28-day cycles until the participant no longer received clinical benefit from therapy in the opinion of the investigator, unacceptable toxicity occurred or the participant met another treatment discontinuation criterion. However, randomization to this arm was removed in protocol version 7.0. Participants previously randomized to this arm continued following treatment and assessments as outlined in the protocol.
Deaths Number Affected:
22
Deaths Number At Risk:
None
Serious Number Affected:
20
Serious Number At Risk:
22
Other Number Affected:
22
Other Number At Risk:
22
Study:
NCT02752035
Results Section:
NCT02752035
Adverse Events Module:
NCT02752035